Novavax, Inc.
(NASDAQ : NVAX)

( )
NVAX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
REGNRegeneron Pharmaceuticals, Inc. -0.09%704.802.6%$681.87m
AMGNAmgen, Inc. 0.00%230.981.4%$641.11m
MRNAModerna, Inc. -0.76%121.220.0%$628.92m
GILDGilead Sciences, Inc. 0.00%63.931.0%$522.23m
BIIBBiogen, Inc. -1.92%271.301.8%$454.56m
VRTXVertex Pharmaceuticals, Inc. -0.48%291.001.9%$389.45m
ILMNIllumina, Inc. -2.13%197.003.2%$316.82m
SNSSSunesis Pharmaceuticals, Inc. 0.00%4.370.7%$305.48m
SAVACassava Sciences, Inc. -1.78%43.060.0%$191.53m
BNTXBioNTech SE -1.59%131.670.0%$107.99m
NVAXNovavax, Inc. -1.43%19.3375.6%$88.78m
BMRNBioMarin Pharmaceutical, Inc. 0.00%85.844.2%$84.06m
NRBONeuroBo Pharmaceuticals, Inc. 3.82%13.850.0%$79.82m
TECHBio-Techne Corp. 0.00%289.654.5%$75.91m
CRSPCRISPR Therapeutics AG -0.66%66.500.6%$74.48m

Company Profile

Novavax, Inc. focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It provides vaccines for COVID-19, seasonal flu, respiratory syncytial virus, Ebola, and Middle East respiratory syndrome. The company was founded in 1987 and is headquartered in Gaithersburg, MD.